Furthermore, high BID expression might inhibit the anti‐inflammatory effects of BCL‐2 by diminishing the activation of the NLRP1 inflammasome and the release of IL1B, disrupting the metabolic balance of the ECM, intensifying local inflammatory responses in disc cells, and resulting in IDD [69]. Here, BCL2 is linked to intervertebral disk degenerative disorder.